AstraZeneca PLC (AZN)
Pre-Market:
| Previous Close | 64.29 |
| Open | 65.27 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1100 |
| Day's Range | 64.20 - 65.28 |
| 52 Week Range | 52.65 - 72.12 |
| Volume | |
| Avg. Volume | 5,109,811 |
| Market Cap | 205.205B |
| Beta (5Y Monthly) | 0.16 |
| PE Ratio (TTM) | 42.47 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.45 (2.52%) |
| Ex-Dividend Date | Aug 11, 2022 |
| 1y Target Est | N/A |
- Reuters
AstraZeneca CEO -discouraging UK tax policies led company to invest $400 million in Ireland
The chief executive of London-listed drugmaker AstraZeneca said on Thursday that discouraging tax policies in the UK led the company to shift plans for a $400 million investment in manufacturing from Britain to Ireland. "We wanted to make (it) in this country but we made it in Ireland because the tax rate was discouraging,” Soriot told a media briefing after the company released its fourth-quarter 2022 results.
- Reuters
UPDATE 1-European shares hit fresh nine-month high on earnings boost
European shares hit a nine-month high on Thursday as Germany's Siemens AG and British drugmaker AstraZeneca boosted earnings euphoria, and helped offset the risk-off sentiment after hawkish Federal Reserve speakers stressed the need for more rate hikes. The pan-European STOXX 600 was up 0.8% at 0920 GMT, extending gains for a third straight session.
- Yahoo Finance UK
FTSE 100: Astrazeneca swings into profit amid double-digit revenue rise
AstraZeneca posted adjusted earnings of $1.38 per share on revenue of $12.2bn.
